ABBV vs RDGT

The Advanced Deterministic Scorecard reveals a mixed health profile with a Piotroski F-Score of 4/9 indicating stable but not strong fundamentals, while the absence of an Altman Z-Score prevents a clear distress risk assessment. Despite robust operating margins and consistent revenue growth, the company faces significant headwinds from negative earnings growth, an extremely high P/E ratio, and a dangerously elevated payout ratio. Strong historical price performance and analyst buy sentiment are counterbalanced by bearish insider activity and deteriorating profitability trends. The stock appears to trade at a substantial premium to its intrinsic value, suggesting limited margin of safety.

Despite a stable Piotroski F-Score of 6/9, RDGT is in a state of catastrophic financial and market collapse. The stock has plummeted from a 52-week high of $760.50 to $2.23, representing a near-total loss of value across all timeframes. Most critically, the provided earnings data is over a decade old (dating back to 2011), suggesting a complete failure in current financial reporting and transparency. The combination of negative revenue growth and a 0/100 technical trend indicates a terminal decline.